There are 3158 resources available
1142O - Multivariable analysis of streptozotocin plus 5-fluorouracil and everolimus sequences in advanced pancreatic neuroendocrine tumor patients: The SEQTOR trial (GETNE-1206)
Presenter: Ramon Salazar Soler
Session: Proffered paper session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 1718O and 1719O
Presenter: Claudia María Valverde Morales
Session: Proffered paper session: Sarcoma
Resources:
Slides
Webcast
Do we have clinical or radiological biomarkers to guide us?
Presenter: Roberto Ferrara
Session: Which patients should we treat beyond progression and when should we stop?
Resources:
Slides
Webcast
Sex and gender: First steps towards tailored treatment
Presenter: Kathrin Heinrich
Session: New technology, new ideas: What is on the horizon for colorectal cancer?
Resources:
Slides
Webcast
CNS disease
Presenter: Nancy Lin
Session: Management of oligoprogressive disease
Resources:
Slides
Webcast
Mantle cell lymphoma
Presenter: Georg Hess
Session: Treatment of difficult lymphomas
Resources:
Webcast
Cardiovascular toxicities: Focus on myocarditis
Presenter: Evandro de Azambuja
Session: Improving the management of toxicities from immunotherapy
Resources:
Slides
Webcast
Challenges of HLA, neoantigen, and immune biomarker testing for early phase immunomodulatory therapy trials
Presenter: Michal Bassani-Sternberg
Session: The evolving diagnostic landscape of early phase trials
Resources:
Webcast
The role of immunotherapy plus concurrent chemoradiation
Presenter: Dina Najjari Jamal
Session: How can we best manage locally-advanced and persistent cervical cancers?
Resources:
Slides
Webcast
How to overcome biases to build Real World Evidence
Presenter: Antonis Valachis
Session: How Real World Data (RWD) are transforming oncology
Resources:
Slides
Webcast